Skip to main content

Table 1 Baseline demographic and clinical characteristics

From: The intensive care infection score – a novel marker for the prediction of infection and its severity

  Group 1 Groups 2 + 3 P
  (n = 149) (n = 152)  
Age (years) 57 (24) 62 (19) 0.01
Gender (male) 100 (67) 105 (69) 0.72
APACHE II score 22 (10) 22 (8) 0.92
APACHE IV score 63 (38) 60 (34) 0.49
SOFA score 7 (7) 8 (6) 0.06
Comorbidity    
 Neurologic 39 (26) 41 (27) 0.88
 Cardiac 40 (27) 58 (38) 0.04
 Pulmonary 28 (19) 38 (25) 0.25
 Gastrointestinal 39 (26) 55 (36) 0.05
 Renal 15 (10) 24 (16) 0.14
 DM II 22 (15) 33 (22) 0.13
 Cancer 22 (15) 46 (30) 0.002
 Autoimmune 7 (5) 8 (5) 0.97
Reasons for ICU admission    <0.001
 Suspected infection 23 (15) 69 (45)  
 Respiratory failure 24 (16) 33 (22)  
 Renal failure 0 (0) 1 (1)  
 Liver failure 5 (3) 3 (2)  
 Neurology 31 (21) 8 (5)  
 CPR 9 (6) 5 (3)  
 Shock 10 (7) 3 (2)  
 Trauma 13 (9) 5 (3)  
 Postoperative 34 (23) 25 (17)  
Treatment on ICU    
 Antibiotics 140 (94) 152 (100) 0.02
 Norepinephrine 109 (73) 128 (84) 0.03
 Dobutamine 18 (12) 17 (11) 0.80
 TPN 39 (26) 50 (33) 0.20
 Mechanical ventilation 133 (89) 125 (82) 0.06
 Renal replacement therapy 15 (10) 52 (34) <0.001
Length of ICU stay (days) 9 (17) 11 (17) 0.49
Length of hospital stay (days) 22 (34) 26 (36) 0.13
Mortality day 28 42 (28) 58 (38) 0.09
Mortality day 90 98 (36) 68 (45) 0.13
  1. Numbers (percentage) or median (interquartile range), where appropriate. Abbreviations: APACHE II acute physiology and chronic health evaluation II, CPR cardiopulmonary resuscitation, DM II diabetes mellitus type II, ECMO extracorporeal membrane oxygenation, SOFA sequential organ failure assessment score, TPN total parenteral nutrition